Hormonal Contraceptive Market Synopsis

Hormonal Contraceptive Market Size Was Valued at USD 18.1 Billion in 2023 and is Projected to Reach USD 26.7 Billion by 2032, Growing at a CAGR of 4.4% From 2024-2032.

Hormonal contraceptives are those contraceptive methods that function in the endocrine system of a woman. These methods include the administration of hormones that are naturally present in women to suppress ovulation and consequently pregnancy. These contraceptives offer no protection against HIV or any other sexually transmitted diseases.

• Rising consciousness in developing countries about the hormonal contraception methods, rising research and development efforts from key players for the advanced contraceptive equipment, and favorable measures taken by governments to improve using contraceptive products are influencing the industry progress. Increasing knowledge about the possibility of not getting pregnant is also likely to increase the growth in the industry.
• There is an increase in cooperation between the key companies and well-known personalities to ensure that people are informed about contraceptives that help to prevent pregnancy. For instance, in July 2019, Allergen Plc teamed up with a musician and actress Ashley Tisdale for the awareness campaign dubbed Women Who Know. The campaign educates women on the various choices they possess concerning protection from pregnancy which includes Loestrin Fe, a hormonal pill manufactured by Allergen. Also, the World Health Organization offered recommendations on the use of hormonal contraception including intra-uterine device, progestogen injectable, and implants for women at higher risk of HIV.
• Moreover, HCs are known to be more effective than condoms and sponges/diaphragms. It was reported by NCBI that a woman would only have a chance of getting pregnant within one year if she is taking these contraceptives correctly. This increase in unmet needs for contraceptive products has greatly contributes to its demand in order to enhance its supply in specific areas globally. According the the World Health Organization (WHO) it is estimated that about 24. A cross-sectional survey conducted amongst women of reproductive age in Africa revealed that 2% have unmet need for modern contraception. In Asia and Latin America & the Caribbean the unmet needs about 10. 2 % and 10. 7%, respectively. The extent such a supply and demand gap is expected to increase during the forecast period and therefore stimulate the market growth.

Hormonal Contraceptive Market Trend Analysis

Increase in Strategic Developments and R&D Activities

• The growing investment in R&D and commercialization of several products launched by the major market players to expand their market share. For instance, the company, Mayne Pharma got approval from the U. S. FDA for NEXTSTELLIS and estetrol for the prevention of pregnancy in 2021. It is the only contraceptive with E4, which is estrogen derived from plants and has fewer positive effects compared to other estrogens. Consequently, it helps to increase market growth.
• Most leading companies associate with immense organizations or celebrities to let the public know the contraceptives that prevent pregnancies. For example, Allergen Plc worked with the actress Ashley Tisdale in the campaign dubbed “Women Who Know” in 2019. The campaign informs women on the many possibilities of birth control measures including the Loestrin Fe, an Allergen hormonal tablet. Thus, there are many strategic advancements that are contributing to the growth rates of the global market.

Increasing Demand for Oral Contraceptives

• The oral contraceptive hormonal pills will have the largest market share expected due to their ease of use and accessibility. Also, some firms are concentrating on the development of new products and the progress of the integrated delivery of hormonal contraceptives, which can be expected to fuel market growth. For instance, in 2022, the Perrigo Company Plc applied for the U. S. FDA approval of one of the first OTC birth control pills in the United States. Opill, a progestin daily birth control pill has been under the process of getting an Rx-to-OTC switch by the company. The current advancements in the types of oral contraceptive pills are believed to boost the market growth rapidly.

Hormonal Contraceptive Market Segment Analysis:

Hormonal Contraceptive Market Segmented based on Method, and Hormone.

By Method, contraceptive pills segment is expected to dominate the market during the forecast period

• According to methods, the industry has been categorized into following categories globally: Pills, IUDs, Injectable Contraceptives, Vaginal Rings, Implants and lastly Patches. The contraceptive pills segment is likely to hold the leading position in the global market in 2022 in terms of overall share of the revenue. They are easy to manage and administer, feasible products, escalating & improved awareness about the pills in contrast to long-acting reversible devices because they entered the market earlier, and a high effectiveness of almost 99% in case of timely consumption.
• Also, advances in technology, existence of major players in the market and increasing maturity in the developing countries are expected to bolster the segment. For example, in July 2021, the MHRA permitted the sale of oral contraceptives for over-the-counter use in pharmacies in the United Kingdom. Two contraceptive pill Hana and Lovima are available over the counter with a health brief consultation by a Pharmacist contains desogestrel-synthetic progesterone. The IUDs segment is presumed to exhibit a comparatively higher growth rate during the given period because of the growing popularity of long-acting methods of contraception. More than 99.0% effectivity, longer action span, no impact of the device to breastfeeding and normal future fertility upon removing of the device that boosted the segment.

By Hormone, combination hormonal contraceptives segment held the largest share in 2023

• By hormones, the global industry has been divided into combination hormonal contraceptives and only progestin. Hormonal contraceptives which include combined oral contraceptives pills and progestin-only pills stood for the biggest share of the total market size in 2021. The segment is also expected to grow at the second fastest growth rate thereby maintaining its leading position during the forecast period. Such reasons include increased chances of getting pregnant since it hinders conception by two mechanisms leading to high success rates. Also, these contraceptives have been found to be safer in relation to the development of acne than progestin-only contraceptives.
• The progestin contraceptives segment is expected to register a growth rate of slightly over 4.5% during the forecast period. One may attribute this to the absence of any estrogen-related side effects including migraines and fluid retention with the medications. These contraceptives have similar consequences and no other contraceptives are needed if the intention is within five days of menses. CDC suggests that of 100, about 9 women may get pregnant if these contraceptives are used as planned.

Hormonal Contraceptive Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• North America was the largest consumer in the industry in 2022 in terms of reveneus share contributing to about 43.0%. Currently, it is expected to remain at the vanguard as expected to grow at the highest Compound Annual Growth Rate (CAGR) of more than 5.0% during the forecast period. This can be said to have been occasioned by the presence of major players, enhanced sexually related awareness and high rates of unwanted pregnancies. For instance, as per the American College of Obstetricians & Gynecologists, about 99 percent of women of childbearing age in the United States are using contraceptives; and about 88 percent of them use only reversible contraception methods like intrauterine devices, implants, rings, patches and others.

Active Key Players in the Hormonal Contraceptive Market

• Abbvie Inc
• Afaxys Inc
• Teva Pharmaceuticals Industries Ltd
• Bayer AG
• Organon Group of Companies
• Pfizer
• Agile Therapeutics
• Janssen Pharmaceuticals Inc
• Lupin Pharmaceuticals Inc
• Pregna International Ltd and Other Active Players

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Hormonal Contraceptive Market by Method
 4.1 Hormonal Contraceptive Market Snapshot and Growth Engine
 4.2 Hormonal Contraceptive Market Overview
 4.3 IUDs
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 IUDs: Geographic Segmentation Analysis
 4.4 Pills
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Pills: Geographic Segmentation Analysis
 4.5 Implants
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Implants: Geographic Segmentation Analysis

Chapter 5: Hormonal Contraceptive Market by Hormone
 5.1 Hormonal Contraceptive Market Snapshot and Growth Engine
 5.2 Hormonal Contraceptive Market Overview
 5.3 Combination Hormonal Contraceptives
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Combination Hormonal Contraceptives: Geographic Segmentation Analysis
 5.4 Progestin-only
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Progestin-only: Geographic Segmentation Analysis

Chapter 6: Company Profiles and Competitive Analysis
 6.1 Competitive Landscape
  6.1.1 Competitive Benchmarking
  6.1.2 Hormonal Contraceptive Market Share by Manufacturer (2023)
  6.1.3 Industry BCG Matrix
  6.1.4 Heat Map Analysis
  6.1.5 Mergers and Acquisitions
  
 6.2 ABBVIE INC
  6.2.1 Company Overview
  6.2.2 Key Executives
  6.2.3 Company Snapshot
  6.2.4 Role of the Company in the Market
  6.2.5 Sustainability and Social Responsibility
  6.2.6 Operating Business Segments
  6.2.7 Product Portfolio
  6.2.8 Business Performance
  6.2.9 Key Strategic Moves and Recent Developments
  6.2.10 SWOT Analysis
 6.3 AFAXYS INC
 6.4 TEVA PHARMACEUTICALS INDUSTRIES LTD
 6.5 BAYER AG
 6.6 ORGANON GROUP OF COMPANIES
 6.7 PFIZER
 6.8 AGILE THERAPEUTICS
 6.9 JANSSEN PHARMACEUTICALS INC
 6.10 LUPIN PHARMACEUTICALS INC
 6.11 PREGNA INTERNATIONAL LTD
 6.12 OTHER ACTIVE PLAYERS

Chapter 7: Global Hormonal Contraceptive Market By Region
 7.1 Overview
 7.2. North America Hormonal Contraceptive Market
  7.2.1 Key Market Trends, Growth Factors and Opportunities
  7.2.2 Top Key Companies
  7.2.3 Historic and Forecasted Market Size by Segments
  7.2.4 Historic and Forecasted Market Size By Method
   7.2.4.1 IUDs
   7.2.4.2 Pills
   7.2.4.3 Implants
  7.2.5 Historic and Forecasted Market Size By Hormone
   7.2.5.1 Combination Hormonal Contraceptives
   7.2.5.2 Progestin-only
  7.2.6 Historic and Forecast Market Size by Country
   7.2.6.1 US
   7.2.6.2 Canada
   7.2.6.3 Mexico
 7.3. Eastern Europe Hormonal Contraceptive Market
  7.3.1 Key Market Trends, Growth Factors and Opportunities
  7.3.2 Top Key Companies
  7.3.3 Historic and Forecasted Market Size by Segments
  7.3.4 Historic and Forecasted Market Size By Method
   7.3.4.1 IUDs
   7.3.4.2 Pills
   7.3.4.3 Implants
  7.3.5 Historic and Forecasted Market Size By Hormone
   7.3.5.1 Combination Hormonal Contraceptives
   7.3.5.2 Progestin-only
  7.3.6 Historic and Forecast Market Size by Country
   7.3.6.1 Bulgaria
   7.3.6.2 The Czech Republic
   7.3.6.3 Hungary
   7.3.6.4 Poland
   7.3.6.5 Romania
   7.3.6.6 Rest of Eastern Europe
 7.4. Western Europe Hormonal Contraceptive Market
  7.4.1 Key Market Trends, Growth Factors and Opportunities
  7.4.2 Top Key Companies
  7.4.3 Historic and Forecasted Market Size by Segments
  7.4.4 Historic and Forecasted Market Size By Method
   7.4.4.1 IUDs
   7.4.4.2 Pills
   7.4.4.3 Implants
  7.4.5 Historic and Forecasted Market Size By Hormone
   7.4.5.1 Combination Hormonal Contraceptives
   7.4.5.2 Progestin-only
  7.4.6 Historic and Forecast Market Size by Country
   7.4.6.1 Germany
   7.4.6.2 UK
   7.4.6.3 France
   7.4.6.4 Netherlands
   7.4.6.5 Italy
   7.4.6.6 Russia
   7.4.6.7 Spain
   7.4.6.8 Rest of Western Europe
 7.5. Asia Pacific Hormonal Contraceptive Market
  7.5.1 Key Market Trends, Growth Factors and Opportunities
  7.5.2 Top Key Companies
  7.5.3 Historic and Forecasted Market Size by Segments
  7.5.4 Historic and Forecasted Market Size By Method
   7.5.4.1 IUDs
   7.5.4.2 Pills
   7.5.4.3 Implants
  7.5.5 Historic and Forecasted Market Size By Hormone
   7.5.5.1 Combination Hormonal Contraceptives
   7.5.5.2 Progestin-only
  7.5.6 Historic and Forecast Market Size by Country
   7.5.6.1 China
   7.5.6.2 India
   7.5.6.3 Japan
   7.5.6.4 South Korea
   7.5.6.5 Malaysia
   7.5.6.6 Thailand
   7.5.6.7 Vietnam
   7.5.6.8 The Philippines
   7.5.6.9 Australia
   7.5.6.10 New Zealand
   7.5.6.11 Rest of APAC
 7.6. Middle East & Africa Hormonal Contraceptive Market
  7.6.1 Key Market Trends, Growth Factors and Opportunities
  7.6.2 Top Key Companies
  7.6.3 Historic and Forecasted Market Size by Segments
  7.6.4 Historic and Forecasted Market Size By Method
   7.6.4.1 IUDs
   7.6.4.2 Pills
   7.6.4.3 Implants
  7.6.5 Historic and Forecasted Market Size By Hormone
   7.6.5.1 Combination Hormonal Contraceptives
   7.6.5.2 Progestin-only
  7.6.6 Historic and Forecast Market Size by Country
   7.6.6.1 Turkey
   7.6.6.2 Bahrain
   7.6.6.3 Kuwait
   7.6.6.4 Saudi Arabia
   7.6.6.5 Qatar
   7.6.6.6 UAE
   7.6.6.7 Israel
   7.6.6.8 South Africa
 7.7. South America Hormonal Contraceptive Market
  7.7.1 Key Market Trends, Growth Factors and Opportunities
  7.7.2 Top Key Companies
  7.7.3 Historic and Forecasted Market Size by Segments
  7.7.4 Historic and Forecasted Market Size By Method
   7.7.4.1 IUDs
   7.7.4.2 Pills
   7.7.4.3 Implants
  7.7.5 Historic and Forecasted Market Size By Hormone
   7.7.5.1 Combination Hormonal Contraceptives
   7.7.5.2 Progestin-only
  7.7.6 Historic and Forecast Market Size by Country
   7.7.6.1 Brazil
   7.7.6.2 Argentina
   7.7.6.3 Rest of SA

Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies

Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research